Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel H Greig

Showing results (11-20 of 332) with videos related to

Pageof 34
Sort By:
Current Alzheimer Research|April 4, 2014
A new regulatory road-map for Alzheimer's disease drug developmentRobert E Becker, Nigel H Greig
Science Translational Medicine|December 15, 2010
Lost in translation: neuropsychiatric drug developmentRobert E Becker, Nigel H Greig
Current Pharmaceutical Design|April 12, 2016
Editorial: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part B)Mohammad A Kamal, Nigel H Greig
Journal of Alzheimer'S Disease : JAD|March 1, 2019
Can We Prevent Dementia and Not Prevent Neurons from Dying?Robert E Becker, Nigel H Greig
Current Alzheimer Research|March 26, 2014
Advances in understanding Alzheimer's disease, and the contributions of current Alzheimer research: ten years on and beyondNigel H Greig, Debomoy K Lahiri
Trends in Neurosciences|February 24, 2019
Microbes and Monoamines: Potential Neuropsychiatric Consequences of DysbiosisStephen D Skolnick, Nigel H Greig
Future Medicinal Chemistry|March 27, 2019
Small molecules as central nervous system therapeutics: old challenges, new directions, and a philosophic divideWilliam A Banks, Nigel H Greig
Current Drug Targets|July 24, 2004
A new Alzheimer's disease interventive strategy: GLP-1Tracy Ann Perry, Nigel H Greig
Current Pharmaceutical Design|September 23, 2016
Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part C))Mohammad A Kamal, Nigel H Greig
Journal of Clinical Psychopharmacology|January 15, 2009
Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?Robert E Becker, Nigel H Greig
Pageof 34

Showing results (11-20 of 332) with videos related to

Sort By:
Pageof 34
Current Alzheimer Research|April 4, 2014
A new regulatory road-map for Alzheimer's disease drug developmentRobert E Becker, Nigel H Greig
Science Translational Medicine|December 15, 2010
Lost in translation: neuropsychiatric drug developmentRobert E Becker, Nigel H Greig
Current Pharmaceutical Design|April 12, 2016
Editorial: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part B)Mohammad A Kamal, Nigel H Greig
Journal of Alzheimer'S Disease : JAD|March 1, 2019
Can We Prevent Dementia and Not Prevent Neurons from Dying?Robert E Becker, Nigel H Greig
Current Alzheimer Research|March 26, 2014
Advances in understanding Alzheimer's disease, and the contributions of current Alzheimer research: ten years on and beyondNigel H Greig, Debomoy K Lahiri
Trends in Neurosciences|February 24, 2019
Microbes and Monoamines: Potential Neuropsychiatric Consequences of DysbiosisStephen D Skolnick, Nigel H Greig
Future Medicinal Chemistry|March 27, 2019
Small molecules as central nervous system therapeutics: old challenges, new directions, and a philosophic divideWilliam A Banks, Nigel H Greig
Current Drug Targets|July 24, 2004
A new Alzheimer's disease interventive strategy: GLP-1Tracy Ann Perry, Nigel H Greig
Current Pharmaceutical Design|September 23, 2016
Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part C))Mohammad A Kamal, Nigel H Greig
Journal of Clinical Psychopharmacology|January 15, 2009
Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?Robert E Becker, Nigel H Greig
Pageof 34